Live from the NIH registry
Studies recruiting near Corona right now
Top 25 of 1,621 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loma Linda University Medical Center (Adults only) — Loma Linda, California (21.7 mi)
· Sponsor: Pierre Fabre Medicament
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (17.3 mi)
· Sponsor: New York Medical College
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Loma Linda University Medical Center — Loma Linda, California (21.7 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (17.3 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Children's Hospital, Orange County — Orange, California (17.3 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (17.3 mi)
· Sponsor: National Cancer Institute (NCI)
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
Tobacco Use, Tobacco Use Cessation
N/A
Interventional 105 participants sought
Riverside University Health Systems — Moreno Valley, California (19.9 mi)
· Sponsor: Loma Linda University
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Chronic Stroke Patients
N/A
Interventional 32 participants sought
University of California Irvine — Irvine, California (19.9 mi)
· Sponsor: University of California, Irvine
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of California, Irvine — Orange, California (17.3 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Newport Beach, California (26.8 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (21.7 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (24.7 mi)
· Sponsor: Takeda
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914 — Irvine, California (19.9 mi)
· Sponsor: AbbVie
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 — Irvine, California (19.9 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Associates of Southern California — Huntington Beach, California (28.6 mi)
· Sponsor: Boehringer Ingelheim
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Orange, California (17.3 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (19.2 mi)
· Sponsor: Genentech, Inc.
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1
Interventional 694 participants sought
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 — Irvine, California (19.9 mi)
· Sponsor: AbbVie
Study of SGN1 in Patients With Advanced Solid Tumor
Advanced Solid Tumor
Phase 1, Phase 2
Interventional 70 participants sought
Health Chao Family Comprehensive Cancer Center — Orange, California (17.3 mi)
· Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of California - Irvine — Irvine, California (19.9 mi)
· Sponsor: AskBio Inc
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Phase 2
Interventional 15 participants sought
Loma Linda University Children's Hospital - PIN — Loma Linda, California (21.7 mi)
· Sponsor: Amgen
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
Alzheimer Disease
Phase 1
Interventional 18 participants sought
Hoag Memorial Hospital Presbyterian — Newport Beach, California (26.8 mi)
· Sponsor: Regeneration Biomedical, Inc.
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (17.3 mi)
· Sponsor: University of California, Irvine
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope - Lennar Foundation Cancer Center — Irvine, California (19.9 mi)
· Sponsor: Hoffmann-La Roche
My Life and My Experiences Project
Stress and Memory in Adolescence
N/A
Interventional 400 participants sought
University of California, Irvine — Irvine, California (19.9 mi)
· Sponsor: University of California, Irvine